Life sciences business systems and methods

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C702S020000

Reexamination Certificate

active

07427480

ABSTRACT:
Improved life sciences business systems and methods are disclosed. One or more genomes are scanned for single nucleotide polymorphisms. The polymorphisms are assigned to haplotype blocks, and representative SNPs from the haplotype blocks are used in association studies for pharmaceutical and diagnostic developments.

REFERENCES:
patent: 5525464 (1996-06-01), Drmanac et al.
patent: 5972614 (1999-10-01), Ruano et al.
patent: 2002/0012921 (2002-01-01), Stanton
patent: WO 01/01218 (2001-01-01), None
patent: WO 01/04270 (2001-01-01), None
Jones, P., “The commercialization of bioinformatics,” EJB Electronic Journal of Biotechnology, vol. 3 No. 2, 96-113, Aug. 15, 2000.
Roses, A., “Pharmacogenetics and future drug development and delivery,” The Lancet, vol. 355, 1358-1361, Apr. 15, 2000.
Goddard, K., et al, “Linkage Disequilibrium and Allele-Frequency Distributions for 114 Sing-Nucleotid Polymorphisms in Five Populations,” The American Journal of Human Genetics, 66:216-234, 2000.
Toivonen, H. et al, “Data Mining Applied to Linkage Disequilibrium Mapping,” The American Journal of Human Genetics, 67:133-145, 2000.
The World of Pharmacia Biotech '95, “Squencing Kit,” p. 177, Copyright 1994.
Patil, N., et al, “Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21,” Science Magazine 294, 1719-1723 (2001).
Daly, M., et al., “High-resolutio nhaplotype structure in the human genome,” Nature Genetics vol. 29, 229-232 (2001).
Oestreicher, P., “4th Annual Pharmacogenomics and Medicine Lectures,” Pharmacogenomics (2001) 2(3):291-296.
Form 10-K filed by Millennium Pharmaceuticals for the fye Dec. 31, 2000.
Form 10-K filed by Applera Corp for the fye Jun. 30, 2001.
Form 10-K filed by Genzyme Corp for the fye Dec. 31, 2000.
Form 10-K filed by Human Genome Sciences, Inc. for the fye Dec. 31, 2000.
Form 10-K filed by Genaissance Pharmaceuticals, Inc. for the fye Dec. 31, 2000.
Perlegen Sciences, Inc. Private Placement Memorandum dated Mar. 30, 2001.
San Jose Mercury News article entitled, “Gene Hunters,” dated Jan. 21, 2002.
Barcellos, L., et al, “Association Mapping of Disease Loci, by Use of a Pooled DNA Genomic Screen,” The American Journal of Human Genetics, 61:734-747, 1997.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Life sciences business systems and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Life sciences business systems and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Life sciences business systems and methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3988537

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.